Cypizone AlphaZone Pharmaceuticals
| Features | |
| Active substance | Testosterone cypionate |
| Also known as | CPA, Cyproterone |
| Blood pressure | Can cause changes in blood pressure |
| Category | Testosterone Cypionate |
| Chemical name | 6-chloro-1ОІ,2ОІ-dihydro-17-hydroxy-3'H-cyclopropa[1,2]pregna-1,4,6-triene-3,20-dione acetate |
| Dosage | 250 Mg |
| Dosage (medical) | 50-100 mg daily |
| Dosage (sports) | Not applicable as it is not used for performance enhancement |
| Dosage Unit | Ml |
| ean13 | 1395341181730 |
| Effects | Reduces androgen activity, lowers testosterone levels |
| FORM | Injection |
| Formula | C24H29ClO4 |
| Half-life | 38 hours |
| Hepatotoxicity | Moderate to high risk |
| Lab Test | Liver function tests |
| Main action | Antiandrogenic and progestogenic |
| Milliliter Size | 10 Ml |
| Reference | ALZNE06 |
| Side effects | Liver toxicity, depressed mood, weight gain, fatigue, decreased libido, menopausal symptoms |
| Storage conditions | Store at room temperature away from moisture and heat |
| Substance class | Steroidal antiandrogen |
| Trade name | Androcur, Cyprostat |
| Use in sports | None, as it does not enhance performance |
| Water Retention | Minimal |
| Packing | Vial |